Table 4.

Adverse events associated with bevacizumab

Adverse events	Total	G1/2, n (%)	G3/4, n (%)
Total	52(33.5)	41(26.5)	11(7.1)
Hypertension	25(16.1)	16(10.3)	9(5.8)
Proteinuria	9(5.8)	9(5.8)	0(0)
Epistaxis	4(2.6)	4(2.6)	0(0)
Nausea	3(1.9)	3(1.9)	0(0)
Headache	2(1.3)	2(1.3)	0(0)
Thrombogenesis	7(4.5)	7(4.5)	0(0)
Impaired wound healing	2(1.3)	2(1.3)	0(0)